Mice deficient in the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1) display a complex retinal phenotype

被引:0
|
作者
Yevgeniya Atiskova
Susanne Bartsch
Tatyana Danyukova
Elke Becker
Christian Hagel
Stephan Storch
Udo Bartsch
机构
[1] University Medical Center Hamburg-Eppendorf,Department of Ophthalmology, Experimental Ophthalmology
[2] University Medical Center Hamburg-Eppendorf,Children´s Hospital, Department of Biochemistry
[3] University Medical Center Hamburg-Eppendorf,Institute of Neuropathology
[4] University Medical Center Hamburg-Eppendorf,Department of Osteology and Biomechanics
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Neuronal ceroid lipofuscinosis (NCL) type 1 (CLN1) is a neurodegenerative storage disorder caused by mutations in the gene encoding the lysosomal enzyme palmitoyl-protein thioesterase 1 (PPT1). CLN1 patients suffer from brain atrophy, mental and motor retardation, seizures, and retinal degeneration ultimately resulting in blindness. Here, we performed an in-depth analysis of the retinal phenotype of a PPT1-deficient mouse, an animal model of this condition. Reactive astrogliosis and microgliosis were evident in mutant retinas prior to the onset of retinal cell loss. Progressive accumulation of storage material, a pronounced dysregulation of various lysosomal proteins, and accumulation of sequestosome/p62-positive aggregates in the inner nuclear layer also preceded retinal degeneration. At advanced stages of the disease, the mutant retina was characterized by a significant loss of ganglion cells, rod and cone photoreceptor cells, and rod and cone bipolar cells. Results demonstrate that PPT1 dysfunction results in early-onset pathological alterations in the mutant retina, followed by a progressive degeneration of various retinal cell types at relatively late stages of the disease. Data will serve as a reference for future work aimed at developing therapeutic strategies for the treatment of retinal degeneration in CLN1 disease.
引用
收藏
相关论文
共 50 条
  • [21] Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome
    Appu, Abhilash P.
    Bagh, Maria B.
    Sadhukhan, Tamal
    Mondal, Avisek
    Casey, Sydney
    Mukherjee, Anil B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2019, 42 (05) : 944 - 954
  • [22] Functional importance of palmitoyl protein thioesterase 1 (PPT1) expression by Sertoli cells in mediating cholesterol metabolism and maintenance of sperm quality
    Zhao, Wenzhen
    Su, Juan
    Wang, Yuntao
    Qian, Tijun
    Liu, Yue
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2019, 86 (08) : 984 - 998
  • [23] Genetic modifiers of Drosophila palmitoyl-protein thioesterase 1-induced degeneration
    Buff, Haley
    Smith, Alexis C.
    Korey, Christopher A.
    GENETICS, 2007, 176 (01) : 209 - 220
  • [24] Identifying cellular pathways modulated by Drosophila palmitoyl-protein thioesterase 1 function
    Saja, Stephanie
    Buff, Haley
    Smith, Alexis C.
    Williams, Tiffany S.
    Korey, Christopher A.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 135 - 145
  • [25] GNS561 AUTOPHAGY BLOCKER, A PALMITOYL-PROTEIN THIOESTERASE 1 (PPT1) INHIBITOR, COMBINED WITH ANTI-PD-1 INCREASES ANTI-TUMOR ACTIVITY OF TRANSGENIC IMMUNOCOMPETENT HEPATOCELLULAR CARCINOMA MOUSE
    Mezouar, Soraya
    Rachid, Madani
    Tijeras-Raballand, Annemilai
    Bestion, Eloine
    Tracz, Jennifer
    Ansaldi, Christelle
    Raymond, Eric
    Halfon, Philippe
    HEPATOLOGY, 2021, 74 : 793A - 793A
  • [26] Status epilepticus induces changes in the expression and localization of endogenous palmitoyl-protein thioesterase 1
    Suopanki, J
    Lintunen, M
    Lahtinen, H
    Haltia, M
    Panula, P
    Baumann, M
    Tyynelä, J
    NEUROBIOLOGY OF DISEASE, 2002, 10 (03) : 247 - 257
  • [27] PON1 has palmitoyl-protein thioesterase (PPT) activity, and can affect the presence of SR-B1 on the endothelial cell membrane
    Ashkar, Rasha
    Khattib, Ali
    Musa, Sanaa
    Goldberg, Doron
    Khatib, Soliman
    BIOFACTORS, 2024, 50 (03) : 608 - 618
  • [28] Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits
    Mitchison, HM
    Hofmann, SL
    Becerra, CHR
    Munroe, PB
    Lake, BD
    Crow, YJ
    Stephenson, JBP
    Williams, RE
    Hofman, IL
    Taschner, PEM
    Martin, JJ
    Philippart, M
    Andermann, E
    Andermann, F
    Mole, SE
    Gardiner, RM
    O'Rawe, AM
    HUMAN MOLECULAR GENETICS, 1998, 7 (02) : 291 - 297
  • [29] Mutations in palmitoyl-protein thioesterase 1 alter exocytosis and endocytosis at synapses in Drosophila larvae
    Aby, Elizabeth
    Gumps, Katherine
    Roth, Amalia
    Sigmon, Stacey
    Jenkins, Sarah E.
    Kim, Joyce J.
    Kramer, Nicholas J.
    Parfitt, Karen D.
    Korey, Christopher A.
    FLY, 2013, 7 (04) : 267 - 279
  • [30] First-in-human phase I, pharmacokinetic (PK), and pharmacodynamic (PD) study of oral GNS561, a palmitoyl-protein thioesterase 1 (PPT1) inhibitor, in patients with primary and secondary liver malignancies.
    Harding, James J.
    Awada, Ahmad
    Decaens, Thomas
    Roth, Gael
    Merle, Philippe
    Kotecki, Nuria
    Dreyer, Chantal
    Ansaldi, Christelle
    Rachid, Madani
    Mezouar, Soraya
    Menut, Agnes
    Bestion, Eloine
    Paradis, Valerie
    Halfon, Philippe
    Raymond, Eric
    Abou-Alfa, Ghassan K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)